US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes
Executive Summary
It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.
You may also be interested in...
FDA’s OTC Monograph User Fees Are Existential Threat To Small Contract Manufacturers, Cosmetics Brands
OMUFA reauthorization should include small business considerations for the US FDA’s OTC Monograph Drug User Fee Program, which established in 2020 a ‘one-size-fits-all’ facility and monograph order request user fee system which could lead to more contract manufacturer exits, a manufacturing bottleneck for OTC cosmetic products, and fewer product choices, says IBA.
Buying Dietary Supplements With Health Savings Accounts Again Placed On Lawmakers’ Plates
House Republicans LaHood, IL, and Curtis, UT, and Democrats Boyle, PA, and Gottheimer, NJ, return to lawmakers’ attention legislation to allow using health savings, flexible spending and similar pre-tax health accounts to buy supplements.
Survey: US Consumers Support Using Health Savings Accounts For Dietary Supplements
Oversample of respondents with FSA/HSAs included to ensure sufficient sample to analyze. All data nationally representative of US adult population and weighted to match US Census characteristics.